Antibody levels high with COVID-19 vaccination for previously infected
Aug 06, 2021
Antibody levels were higher in the previously infected versus infection-naive after one dose of BNT162b2 vaccine.
Brookdale wins $35 million Medicare fraud lawsuit
By
Lois A. Bowers
Jun 26, 2017
A federal judge has permanently dismissed a lawsuit in which a former employee accused Brookdale Senior Living and subsidiaries of submitting approximately $35 million in fraudulent Medicare claims for...
New COVID-19 cases 300 percent higher this Labor Day weekend than last year
Sep 07, 2021
The surge in new cases could really hit a high point in about two weeks from now.
Erickson Living receives Corporate Health Achievement Award
Apr 14, 2016
Erickson Living has received the American College of Occupational and Environmental Medicine’s Corporate Health Achievement Award in recognition of its efforts related to the health and safety of...
Department of Labor announces virus-related liability protections in light of executive order
By
Amy Novotney
Apr 29, 2020
In a move that may provide leverage in the battle for legal immunity for long-term care providers, the Department of Labor released a statement Tuesday providing some liability protections for meat industry...
Achieving treatment goals in T2DM can up life expectancy
Apr 19, 2022
Life expectancy gains were seen with reducing HbA1c, SBP, LDL-C and BMI among individuals with type 2 diabetes.
Adding tirzepatide to insulin glargine ups glycemic control in type 2 diabetes mellitus
Feb 10, 2022
For adults with type 2 diabetes and inadequate glycemic control, glycemic control improved with the addition of tirzepatide versus placebo.
More intensive LDL-C lowering may cut recurrent stroke risk
Feb 22, 2022
More intensive LDL-C-lowering with statin-based therapies was linked to a reduced risk for recurrent stroke for patients with evidence of atherosclerosis.
Dopamine agonists, DRIs similar for quality of life in Parkinson’s disease
Dec 29, 2021
The research “suggests that MAO-B inhibitors might be underused as adjuvant therapy for the treatment of people with Parkinson disease.”
New Alzheimer’s disease drug delivers disappointing results
Jun 17, 2022
The trial was the first to test a drug meant to delay or halt mental decline in people who have a genetic predisposition.